Summary: A typical Medicare beneficiary pays about $414 a year in Part D premiums plus drug out-of-pocket costs that now max out at $2,100. The 2026 standard benefit sets a $615 deductible, 25 percent coinsurance after that, and the $2,100 cap on covered drugs. This guide explains each piece, works through three realistic drug-spending scenarios, and flags the costs people forget to budget.
Part D costs come in two buckets that do not mix: premiums, which you pay every month regardless, and drug cost-sharing, which depends on what you take. The buckets have separate rules, separate averages, and separate traps. Most confusion about Part D comes from blending them.
The sections below price each bucket from the CMS 2026 parameters, then combine them in worked examples so you can map your own situation onto the math.
Only your out-of-pocket spending on covered Part D drugs counts toward the $2,100 cap: deductibles you pay, coinsurance and copays on covered drugs. Manufacturer discounts and plan payments do not count, and neither do premiums. This is why two beneficiaries with identical drug lists can hit the cap in different months: tier placement and deductible design change how fast your own dollars accumulate.
Track your progress on your plan's explanation of benefits, which shows your year-to-date out-of-pocket total. Once you cross $2,100, covered prescriptions should adjudicate at $0 at the pharmacy; if they do not, call the plan before paying, because pharmacy billing errors at the cap boundary are common and fixable.
The national base beneficiary premium for 2026 is $38.99 a month. That figure is used to compute late enrollment penalties and is not what most people actually pay. CMS projected the average standalone Part D premium at about $34.50 a month for 2026, down from $38.31 in 2025, helped by the premium stabilization demonstration.
Actual premiums vary widely by plan and region, from under $10 to over $100 a month. Low premiums are not automatically a deal: plans compete on premium while differing on deductibles, tier copays, and formularies. The premium bucket is the smallest part of most beneficiaries' total drug spending, which is why shopping on premium alone misfires.
The 2026 standard deductible is $615: you pay the first $615 of covered drug costs yourself. Not every plan charges the full amount; some charge less and some waive it for preferred generics. After the deductible, you pay 25 percent of covered drug costs in the initial coverage phase.
The 25 percent is the standard; many plans use tiered copays instead, like $5 for preferred generics and $45 for preferred brands. Copay plans and coinsurance plans can produce very different totals for the same drug list, which is why entering your specific medications into Medicare's plan finder beats any rule of thumb.
Once your out-of-pocket spending on covered drugs reaches $2,100 in 2026, you pay $0 for covered drugs the rest of the year. This cap, created by the Inflation Reduction Act, started at $2,000 in 2025 and is indexed to drug spending growth. It is the program's most important protection: no beneficiary pays more than $2,100 a year for covered Part D drugs, no matter how expensive their medications.
Two caveats. First, premiums do not count toward the cap. Second, only covered drugs count: a drug your plan does not cover neither gets the cap's protection nor moves you toward it. Formulary coverage is the gate; the cap is the ceiling.
Light user: $800 a year in retail drug costs, $34.50 premium, standard deductible. You pay the $615 deductible? No: you pay the first $800 only up to the deductible, so $615, plus 25 percent of the remaining $185, or $46.25. Drug out-of-pocket: $661.25. Plus $414 in premiums: $1,075.25 total.
Moderate user: $3,000 in retail costs. Deductible $615, then 25 percent of $2,385 is $596.25. Drug out-of-pocket $1,211.25, plus $414 premiums, total $1,625.25. Heavy user: $20,000 in retail costs. You blow through to the cap: $2,100 drug out-of-pocket plus $414 premiums, total $2,514. The cap saves the heavy user over $15,000 versus the old benefit.
The premium bucket surprises: Part D premiums are often deducted from Social Security, so beneficiaries never see the bill and underestimate the cost. The non-covered drug trap surprises harder: a single expensive non-formulary drug can cost more out of pocket than the entire $2,100 cap protects, because it sits outside the cap entirely.
Pharmacy choice matters too. Preferred pharmacies in your plan's network can cut copays substantially versus out-of-network fills, and mail order often prices 90-day supplies below three retail fills. These are small optimizations that compound across a year of prescriptions.
CMS has set the 2027 parameters: the deductible rises to $700 and the out-of-pocket cap to $2,400, with the base beneficiary premium at $41.33. The premium stabilization demonstration ends after 2026, which may move individual plan premiums more than the averages suggest.
The direction is consistent: caps and deductibles indexed upward, premiums normalizing. None of it changes the shopping strategy: enter your drugs, compare total annual cost, and re-shop every open enrollment.
$615 under the standard benefit. Many plans charge less or waive it for certain drug tiers.
$2,100 in out-of-pocket costs for covered drugs, plus your premiums. After the cap, covered drugs cost $0.
No. Premiums are separate and do not count toward the $2,100 cap.
The cap rises to $2,400 and the deductible to $700. Individual plan premiums may move more as the premium stabilization demonstration ends.
Figures: CMS 2026 and 2027 Part D parameters. Verify your plan's formulary and premiums. This guide is for planning only.